Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
Authors
Keywords
Gastric cancer, Tumor marker, Biomarker, Prognosis, Chemotherapy
Journal
SURGERY TODAY
Volume 48, Issue 4, Pages 388-394
Publisher
Springer Nature
Online
2017-10-17
DOI
10.1007/s00595-017-1598-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and feasibility of laparoscopic gastrectomy for gastric cancer patients with a history of abdominal surgery
- (2017) Kotaro Yamashita et al. SURGERY TODAY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer
- (2016) Yuichiro Kato et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer
- (2016) Tsutomu Namikawa et al. ONCOLOGY
- The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases
- (2016) Noriko Wada et al. SURGERY TODAY
- Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1)
- (2015) T. Namikawa et al. EJSO
- The Prognostic Significance of Pretreatment Serum CEA Levels in Gastric Cancer: A Meta-Analysis Including 14651 Patients
- (2015) Kai Deng et al. PLoS One
- Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria
- (2015) Hiroshi Katayama et al. SURGERY TODAY
- Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients
- (2015) Dae Hoon Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Emerging blood-based biomarkers for detection of gastric cancer
- (2015) Zane Kalniņa WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
- (2015) Zhipeng Sun et al. World Journal of Surgical Oncology
- Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer
- (2014) Qing Wang et al. MEDICAL ONCOLOGY
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
- (2013) Hideaki Shimada et al. Gastric Cancer
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
- (2009) Narikazu Boku et al. LANCET ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now